Adaptive Immunity and the Tumor Microenvironment-Reference-Cited by-同舟云学术

Adaptive Immunity and the Tumor Microenvironment

Published:2020 Issue: Volume: Page:111-147
ISSN:0927-3042
Container-title:Cancer Treatment and Research
language:
Short-container-title:

Author:

Han ,Lotze

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-38862-1_4

Reference162 articles.

1. Vakkila J, Jaffe R, Michelow M, Lotze MT (2006) Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors. Clin Cancer Res 12(7 Pt 1):2049–2054. https://doi.org/10.1158/1078-0432.CCR-05-1824 PubMed PMID: 16609014

2. Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A (2017) Comprehensive analysis of hypermutation in human cancer. Cell 171(5):1042–1056. https://doi.org/10.1016/j.cell.2017.09.048 . PubMed PMID: 29056344; PMCID: PMC5849393

3. Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, Kaufman HL, Kirchhoff T, Lotze MT, Luke JJ, Minn AJ, Politi K, Shultz LD, Simon R, Thorsson V, Weidhaas JB, Ascierto ML, Ascierto PA, Barnes JM, Barsan V, Bommareddy PK, Bot A, Church SE, Ciliberto G, De Maria A, Draganov D, Ho WS, McGee HM, Monette A, Murphy JF, Nistico P, Park W, Patel M, Quigley M, Radvanyi L, Raftopoulos H, Rudqvist NP, Snyder A, Sweis RF, Valpione S, Butterfield LH, Disis ML, Fox BA, Cesano A, Marincola FM, Society for Immunotherapy of Cancer Cancer Immune Responsiveness Task F, Working G (2019) Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. J Immunother Cancer 7(1):131. https://doi.org/10.1186/s40425-019-0602-4 . PubMed PMID: 31113486

4. Filbin M, Monje M (2019) Developmental origins and emerging therapeutic opportunities for childhood cancer. Nat Med 25(3):367–576. https://doi.org/10.1038/s41591-019-0383-9 PubMed PMID: 30842674

5. Lotze MT, Demarco RA (2004) Dying dangerously: necrotic cell death and chronic inflammation promote tumor growth. Discov Med. 4(24):448–556 PubMed PMID: 20704947

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies;Frontiers in Immunology;2023-04-17

2. Immune repertoire analysis of normal Chinese donors at different ages;Cell Proliferation;2022-08-04

3. Intrapleural interleukin-2–expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease;The Journal of Thoracic and Cardiovascular Surgery;2020-12